VINAY GULATI, M.D.
Nuclear Cardiology Physician in HARTFORD, Connecticut. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.
What the federal data shows
VINAY GULATI, M.D. filed 2,536 Medicare Part D claims in 2023 as a Nuclear Cardiology Physician in HARTFORD, Connecticut, prescribing 86% generic.
- 3K
- Part D claims, 2023
- 86%
- generic prescribing
- Likely
- board-certified (heuristic)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.
VINAY GULATI, M.D.'s Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2023 — across all CMS prescribers nationally
2,536 Top 13% higher than 87% of 1,370,886 prescribers
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source CMS Medicare Part D Prescriber Public Use File · 2023
VINAY GULATI, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + 4 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about VINAY GULATI, M.D.?
Quality data not reportedPrimary specialty
Medicare Part D claims
Specialty distribution in Connecticut
How Nuclear Cardiology Physician compares to other specialties among Connecticut providers
Nuclear Cardiology Physician share within Connecticut
Nuclear Cardiology Physician is one of the more visible NUCC categories in Connecticut
Each bar reflects the share of in-state providers whose primary NUCC taxonomy matches the specialty. Long tail of ~690 NUCC codes folded into "Other" to keep the comparison legible.
Specialty board-certification context
Estimated specialty board-certified rate — Nuclear Cardiology Physician (ABMS / AOA reference)
- Est. board-certified rate
- 78%
- Nuclear Cardiology Physician ABMS/AOA estimate
Est. board-certified rate (Nuclear Cardiology Physician) — ABMS / AOA estimate
Verify credentials
- Verify via ABMS free public lookup
- Verify via AOA osteopathic boards
- Specialty volume Nuclear Cardiology Physician US NPIs
Specialty board-certified rate — Nuclear Cardiology Physician estimate
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus Maintenance of Certification cycles. CMS does not publish a per-provider board-certification field; the figure shown is the specialty-level estimated rate from ABMS / AOA reference data.
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
VINAY GULATI, M.D. appears in the CMS NPPES registry as a Nuclear Cardiology Physician provider holding M.D. credentials at 80 SEYMOUR ST, HARTFORD, CT, 06102, with a listed phone of (860) 972-5020. NPI 1275832370 was issued on 03/15/2011. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what GULATI most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.
Medicare Part D records for calendar year 2023 show 2,536 prescription claims written by this provider, covering 366 Medicare beneficiaries and totaling roughly $449K in drug spend, split 14% brand-name and 86% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.
Nuclear Cardiology Physician is a narrow specialty nationwide, with 374 enrolled providers across 37 states and an average of 4,019 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.
Practice Address
Provider Details
| NPI | 1275832370 |
|---|---|
| Specialty | Nuclear Cardiology Physician |
| Credentials | M.D. |
| Gender | Male |
| NPI Issued | 03/15/2011 |
Verify this provider's license
PlainDoctor pulls this profile from the CMS NPPES public registry. Confirm VINAY GULATI, M.D.'s current license status, disciplinary history, and board certifications with the Connecticut Department of Public Health in Connecticut before relying on this page for a clinical or care decision.
How we sourced this profile
Hospital and facility affiliations
Facilities where VINAY GULATI, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.
Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).
Industry payments received (2024) — CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for VINAY GULATI, M.D.. Source: openpaymentsdata.cms.gov.
Total received
$1.3K
Largest payer
Actelion Pharmaceuticals US, Inc.
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias — they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Typical
14% brand-name claims vs 86% generic, on 2,536 2023 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2023.
Prescribing Breakdown
- 30-Day Fills
- 6,097
- Total Day Supply
- 182,348
- Brand vs Generic
- 14% brand / 86% generic
- Brand Drug Cost
- $402K
- Generic Drug Cost
- $47K
Patient Demographics
- Average Patient Age
- 71.8 years
- Avg HCC Risk Score
- 1.70
- Gender Split
- 54% female / 46% male
- Age Distribution
- <65: 50, 65-74: 178, 75-84: 113, 85+: 25
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.
What VINAY GULATI, M.D. prescribes most
Top Medicare Part D drugs by claim count, 2023
- Amlodipine Besylate
Amlodipine Besylate
355 claims
- Metoprolol Succinate
Metoprolol Succinate
258 claims
- Losartan Potassium
Losartan Potassium
192 claims
- Atorvastatin Calcium
Atorvastatin Calcium
185 claims
- Metoprolol Tartrate 139
Metoprolol Tartrate
139 claims
- Carvedilol 115
Carvedilol
115 claims
- Furosemide 112
Furosemide
112 claims
- Eliquis 110
Eliquis
110 claims
| Drug | Claims |
|---|---|
| Amlodipine Besylate | 355 |
| Metoprolol Succinate | 258 |
| Losartan Potassium | 192 |
| Atorvastatin Calcium | 185 |
| Metoprolol Tartrate | 139 |
| Carvedilol | 115 |
| Furosemide | 112 |
| Eliquis Apixaban | 110 |
| Hydrochlorothiazide | 92 |
| Rosuvastatin Calcium | 77 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Nuclear Cardiology Physician Overview
How VINAY GULATI, M.D. fits within the Nuclear Cardiology Physician landscape nationally.
VINAY GULATI, M.D.'s 2,536 claims are below the specialty average of 4,019.
Nearby Nuclear Cardiology Physician Providers in Connecticut
Other clinicians with the same primary specialty enrolled in Connecticut, drawn from the same CMS NPPES roster as GULATI.
Compare Nuclear Cardiology Physician nationally: see state-by-state distribution →
Healthcare Guides
Learn more about finding, verifying, and understanding healthcare providers.
Explore Connecticut
Frequently Asked Questions
What is VINAY GULATI, M.D.'s specialty? ▼
How much does VINAY GULATI, M.D. prescribe under Medicare Part D? ▼
Where is VINAY GULATI, M.D. located? ▼
What is VINAY GULATI, M.D.'s NPI number? ▼
Does VINAY GULATI, M.D. prescribe more brand-name or generic drugs? ▼
How many Nuclear Cardiology Physician providers are there in the US? ▼
What drugs does VINAY GULATI, M.D. prescribe most often? ▼
Does VINAY GULATI, M.D. accept Medicare? ▼
How can I verify VINAY GULATI, M.D.'s credentials? ▼
Data Sources
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology